Project Details
Description
A Therapeutic Trial of Bortezomib (Velcade), Vorinostat (SAHA) and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LL)
| Status | Finished |
|---|---|
| Effective start/end date | 9/16/10 → 3/31/13 |
Funding
- MILLENIUM PHARM
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.